{
    "nct_id": "NCT05278065",
    "official_title": "Complimentary Electronic Cigarettes for Harm Reduction Among Adult Smokers With Asthma",
    "inclusion_criteria": "* Male or female (50%), 21 to 65 (inclusive) years of age;\n* Persistent asthma symptoms (i.e., episodic symptoms of airflow obstruction / airway hyperresponsiveness (AHR) as documented in review of medical history);\n* Currently prescribed SABA medication;\n* Past-year smoking of ≥5 cigarettes/day;\n* Exhaled CO ≥ 6 ppm at baseline;\n* Zero breath alcohol during informed consent for participation;\n* English-speaking at an 8th grade level.\nHealthy volunteers allowed\nMust have minimum age of 21 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* Intention to quit smoking during the next 30 days;\n* Current engagement in any smoking cessation treatment;\n* Current self-identification as regular ENDS user or using ENDS > 2 days / week;\n* Medical contraindication to nicotine;\n* Pregnancy (due to toxicity of nicotine and tobacco products);\n* Current alcohol dependence (AUDIT > 15)\n* Urine-screened or past-month self-reported use of illicit substances (amphetamine, cocaine, methamphetamine, opioids, benzodiazepines);\n* Current psychosis, mania, or suicidal ideation;",
    "miscellaneous_criteria": ""
}